Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | MTOR | P42345 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CETP | P11597 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | UBE2N | P61088 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17677400 | 1.00 | USP2 (0.56) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL14511078 | 1.00 | USP2 (0.56) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL16277114 | 1.00 | USP2 (0.56) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL530879 | 1.00 | USP2 (0.56) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL17237491 | 1.00 | USP2 (0.56) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL3294751 | 0.98 | USP2 (0.53) | USP2LMNAKDM4EDUSP3MEN1 | |
| Sulfuric Acid SCHEMBL8349091 | 0.92 | USP2 (0.49) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL7203820 | 0.90 | DGKA (0.57) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL16254836 | 0.90 | DGKA (0.57) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL3395699 | 0.85 | USP2 (0.56) | USP2LMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2320863-B1 | CLEANSING COMPOSITION | KAO GERMANY GMBH (DE) | 2018-05-16 | — | — | EP | claimed |
| EP-2320855-B1 | CONDITIONING COMPOSITION FOR HAIR | KAO GERMANY GMBH (DE) | 2017-12-27 | — | — | EP | claimed |
| EP-2320862-B1 | CLEANSING COMPOSITION | KAO GERMANY GMBH (DE) | 2016-04-27 | — | — | EP | claimed |
| EP-2320856-B1 | CONDITIONING COMPOSITION FOR HAIR | KAO GERMANY GMBH (DE) | 2015-11-11 | — | — | EP | claimed |
| US-12031006-B2 | Use of polyolethers for producing porous plastic coatings | EVONIK OPERATIONS GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| CN-114901237-A | Oil-in-water emulsion cosmetic | LVMH研究公司 | 2022-08-12 | — | — | CN | disclosed |
| US-20200207938-A1 | USE OF POLYOLETHERS FOR PRODUCING POROUS PLASTIC COATINGS | EVONIK OPERATIONS GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
| US-9937140-B2 | Branched chain amino acids: formulations and methods of treatment | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2018-04-10 | — | — | US | disclosed |
| CN-107029229-A | The method for preparing vesica and the preparation being generated by it | 变异生物技术公司 | 2017-08-11 | — | — | CN | disclosed |
| US-20150126604-A1 | BRANCHED CHAIN AMINO ACIDS: FORMULATIONS AND METHODS OF TREATMENT | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-05-07 | — | — | US | disclosed |
| US-6001376-A | COSMETIC COMPOSITIONS FOR THE TREATMENT OF KERATINOUS SUBSTANCES AND FOR BUCCODENTAL HYGIENE | L'OREAL (FR) | 1999-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126604-A1 | BRANCHED CHAIN AMINO ACIDS: FORMULATIONS AND METHODS OF TREATMENT | GLS, BCAT2, ARG2 | USP2 1372/4885LMNA 863/4885KDM4E 3126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.